---
created: 2025-04-13
updated: 2025-04-13T10:53
id: o(e?G}ZT+?
specialty: pharmaco
specialty_id: 568
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - source/ak-step1-v11::!flag-these-cards::potential-duplicates
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::50-ganciclovir
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::28-antivirals
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::02-antivirals::03-ganciclovir-&-valganciclovir
  - "source/ak-step1-v11:": 
  - theme/pixorize::04-micro::03-antivirals::ganciclovir-valganciclovir
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::07-antivirals-other::03-ganciclovir,-valganciclovir,-foscarnet,-cidofovir
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1644"
type: flashcard
---

# Question
IV antiviral agent that inhibits DNA polymerase and reverse transcriptase, the pyrophosphate analog **foscarnet** does not require intracellular activation by viral or cellular kinases.

---

# Answer
Ganciclovir requires intracellular activation by cellular kinases